Document is current
Any future updates will be listed below
-
Authors
Prinz, Daniela
Bartsch, Silvester J.
Friske, Joachim
Krššák, Martin
Laimer-Gruber, Daniela
Helbich, Thomas H.
Pinker, Katja https://orcid.org/0000-0002-2722-7331
-
Funding
Funding for this research was provided by:
Vienna Science and Technology Fund (LS19-018)
- License Information
-
More Information
Article History
Received: 26 June 2025
Accepted: 24 November 2025
First Online: 19 January 2026
Declarations
:
: All studies involving laboratory research animals were approved by the Austrian Federal Ministry of Education, Science and Research [66.009/0284-WF/V/3b/2017; 2020–0.363.124; 2022–0.726.820] and the Intramural Committee for Animal Experimentation of the Medical University of Vienna. Study procedures were in accordance with the European Community’s Council Directive of 22 September 2010 (2010/63/EU), and all data reported in the study adhered to ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.
: Not applicable.
: KP: speakers bureaus for the European Society of Breast Imaging (EUSOBI) (active) and consulting for Bayer, Guerbet, AURA Health Technologies, Neodynamics and Focus West Health. THH: speakers bureaus for the European Society of Breast Imaging (EUSOBI) (active) and cooperation with Bracco, Siemens Healthineers, Guerbet, Novomed, Bruker and BD. THH is also a member of the European Radiology Experimental Scientific Editorial Board (section editor: molecular, nuclear and hybrid imaging) and, as such, did not participate in the selection or review processes for this article. The remaining authors declare that they have no competing interests.
